01 April 2004
Yogurt feeding inhibits promotion and progression of experimental colorectal cancer
Alejandra de Moreno de LeBlanc, Gabriela PerdigónMed Sci Monit 2004; 10(4): BR96-104 :: ID: 11626
Abstract
Background: In BALB/c mice, a yogurt diet given before and after the carcinogen 1, 2 dymethylhydrazine
(DMH) inhibited colon cancer. This paper studied at which stage of tumor development (initiation, promotion or progression) yogurt exerts its antitumor activity.
Material/Methods: Six experimental groups were used: 1) non-treatment control; 2) DMH control; 3) yogurt-
DMH-yogurt: yogurt administered before and after DMH. 4) yogurt-DMH: yogurt given only
10 days before DMH; 5) DMH-yogurt: yogurt given cyclically after DMH; and 6) yogurt control. The groups DMH-yogurt and yogurt-DMH were compared histologically and TNFα, INFγ, IL-10 and IL-4 cytokines, CD4[sup]+[/sup]/CD25[sup]+[/sup] T cells, and apoptotic cells were determined in large intestine biopsies. TNFα and INFγ were also determined in cells isolated from large
intestine nodules and from Peyer’s patches.
Results: The DMH-yogurt group did not develop tumor. The yogurt-DMH group showed only tumor
delay; TNFα, INFγ and IL-10 increasing in this group in all the periods assayed. These results agree with those already reported for DMH control and yogurt-DMH-yogurt. There was no correlation between the high levels of IL-10 and CD4[sup]+[/sup]/CD25+ T regulatory population. IL-4 and apoptotic cells increased in the yogurt-DMH group only in the first months. In the DMHyogurt group, cellular apoptosis increased during the whole treatment. Yogurt feeding
induced TNFα and INFγ increases in cells isolated from large intestine nodules. These cytokines also increased in cells from Peyer’s patches of the yogurt control group.
Conclusions: These results show that yogurt inhibited tumor progression and promotion by modulating the immune response and stimulating cellular apoptosis.
Keywords: 1,2-Dimethylhydrazine - toxicity, Antigens, CD4 - immunology, Apoptosis - physiology, Carcinogens - toxicity, Colorectal Neoplasms - chemically induced, Colorectal Neoplasms - diet therapy, Cytokines - metabolism, Intestines - immunology, Intestines - pathology, Peyer's Patches - immunology, Peyer's Patches - pathology, Receptors, Interleukin-2 - immunology, T-Lymphocytes - cytology, T-Lymphocytes - immunology, Yogurt - microbiology, 1,2-Dimethylhydrazine - toxicity, Antigens, CD4 - immunology, Apoptosis - physiology, Carcinogens - toxicity, Colorectal Neoplasms - diet therapy, Cytokines - metabolism, Intestines - pathology, Peyer's Patches - pathology, Receptors, Interleukin-2 - immunology, T-Lymphocytes - immunology, Yogurt - microbiology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952